Showing results (2191-2200 of 2,629) with videos related to

Sort By:
Pageof 263
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2013
Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancerJennifer Y Wo, Harvey J Mamon, Cristina R Ferrone, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2026
NRG-GI007: Phase I study of OBP-301, an oncolytic virus, and definitive chemoradiation in locally advanced esophageal cancerGeoffrey Y Ku, Kathryn Winter, David Ilson, et al.
Acta Neurologica Scandinavica|March 24, 2011
Comparison of 90-day case-fatality after ischemic stroke between two different stroke outcome registries using propensity score matching analysisK-H Yu, K-S Hong, B-C Lee, et al.
Journal of Nanoscience and Nanotechnology|November 18, 2009
Synthesis and electrochemical studies of nano-scale carbon-coated LiFePO4 electrodes for Li-ion batteriesEuh Duck Jeong, Hye Jin Kim, Chang Won Ahn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2017
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumorsY J Bang, G Giaccone, S A Im, et al.
Cancer|September 6, 2013
Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010Sophie Cai, Theodore S Hong, Saveli I Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisRanda Tao, Sunil Krishnan, Priya R Bhosale, et al.
Oncoscience|January 17, 2015
MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitorsChad Tang, Denis L Fontes Jardim, Gerald S Falchook, et al.
European Radiology|October 19, 2021
Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapyYoshifumi Noda, Nisanard Pisuchpen, Nathaniel D Mercaldo, et al.
Annals of Surgery|September 13, 2012
Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?Ioannis T Konstantinidis, Andrew L Warshaw, Jill N Allen, et al.
Pageof 263